Poster Abstracts
Grand Hall CD (Manchester Grand Hyatt)
Early CD4+ Immune Reconstitution Predicts Probability of Relapse in Pediatric AML after Unrelated Cord Blood Transplantation: Importance of Preventing in Vivo T-Cell Depletion Using Thymoglobulin®
Rick Admiraal, MD, University Medical Center Utrecht;
Robert Chiesa, MD, PhD, Great Ormond Street Hospital for Children;
Marc Bierings, MD, PhD, University Medical Center Utrecht;
A. Birgitta Versluijs, MD, University Medical Center Utrecht;
Prashant Hiwarkar, MD, Great Ormond Street Hospital for Children NHS Trust;
Juliana Silva, MD, Great Ormond Street Hospital for Children NHS Trust;
Paul Veys, MBBS, Great Ormond Street Hospital for Children;
Jaap-Jan Boelens, MD, PhD, University Medical Center Utrecht
Higher Incidence of Grade III and IV Toxicities in Adolescents Undergoing Allogeneic Hematopoietic Cell Transplantation and Its Impact on Mortality at One Year Post-Transplant: A Retrospective Cohort Study of Pediatric Patients Undergoing Allogeneic Stem
Naima Al Mulla, M.D., New York Presbyterian Hospital- Columbia University Medical Center;
Justine Kahn, MD, New York Presbyterian Hospital- Columbia University Medical Center;
Mahvish Qureshi, MD, New York Presbyterian Hospital- Columbia University Medical Center;
Grace Kim, New York Presbyterian Hospital- Columbia University Medical Center;
Zhezhen Jin, PhD, Columbia University;
Anya Levinson, Columbia University;
Monica Bhatia, MD, Columbia University;
Esra Karamehmet, Columbia University Medical Center;
James Garvin, MD, PhD, Columbia University;
Diane George, MD, Columbia University;
Andrew Kung, MD, PhD, Columbia University;
Prakash Satwani, MD, Columbia University Medical Center
Health-Related Quality of Life and Perception of Care of Mucopolysaccharidosis Type I - Hurler Syndrome Patients after Successful Hematopoietic Cell Transplantation: A Parents' Perspective
Mieke Aldenhoven, MD, University Medical Center Utrecht;
Robert F. Wynn, MD, Royal Manchester Children's Hospital;
Anne O'Meara, MD, Our Lady's Children's Hospital;
Paul Veys, MBBS, Great Ormond Street Hospital for Children;
Attilio Rovelli, MD, San Gerardo University Hospital;
Simon A. Jones, MD, University of Manchester;
Rossella Parini, MD, San Gerardo University Hospital;
Marleen Renard, MD, University Hospital Leuven;
Victoria Bordon, MD, Ghent University Hospital;
Tom J. de Koning, MD, University Groningen, University Medical Center Groningen;
Jaap-Jan Boelens, MD, PhD, University Medical Center Utrecht
Preemptive Immunotherapy Based on Post-Transplant Chimerism and MRD Monitoring Is an Effective Strategy to Prevent Relapse after Allogeneic Stem Cell Transplantation in Children with ALL: A Single Center Experience
Peter Bader, Klinik für Kinder und Jugendmedizin;
Eva Rettinger, Klinik für Kinder und Jugendmedizin;
Michael Merker, Klinik für Kinder und Jugendmedizin;
Hermann Kreyenberg, Klinik für Kinder und Jugendmedizin;
Thomas Krenn, University Children's Hospital;
Matthias Dürken, University Children's Hospital;
Jörg Faber, University Children's Hospital;
Sabine Huenecke, Klinik für Kinder und Jugendmedizin;
Claudia Brehm, Klinik für Kinder und Jugendmedizin;
Melanie Bremm, Klinik für Kinder und Jugendmedizin;
Andre Willasch, Klinik für Kinder und Jugendmedizin;
Emilia Salzmann-Manrique, Klinik für Kinder und Jugendmedizin;
Andrea Jarisch, Klinik für Kinder und Jugendmedizin;
Jan Soerensen, Klinik für Kinder und Jugendmedizin;
Evelyn Ullrich, Klinik für Kinder und Jugendmedizin;
Thomas E Klingebiel, Klinik für Kinder und Jugendmedizin
Alemtuzumab Administration in Reduced Toxicity Conditioning (RTC) Regimens Prior to Allogeneic Hematopoietic Cell Transplantation (AlloHCT). What Matters Most – Timing or Donor Source?
Monica Bhatia, MD, Columbia University;
Matthew Lee, University of California, San Francisco;
Katherine Costa, MD, Johns Hopkins University Medical Center;
Zhezhen Jin, PhD, Columbia University;
Esra Karamehmet, Columbia University Medical Center;
James Garvin, MD, PhD, Columbia University;
Diane George, MD, Columbia University;
Andrew Kung, MD, PhD, Columbia University;
Christopher C. Dvorak, MD, University of San Francisco;
Biljana Horn, MD, UCSF Benioff Children's Hospital;
Prakash Satwani, MD, Columbia University Medical Center
Predicting Relapse Post-Hematopoietic Stem Cell Transplant for Pediatric AML and MDS
Larisa Broglie, MD, Ann & Robert H. Lurie Children's Hospital of Chicago;
Sonali Chaudhury, MD, Ann & Robert H. Lurie Children's Hospital of Chicago;
Irene Helenowski, MS, PhD, Feinberg School of Medicine, Northwestern University;
Larry Jennings, MD, PhD, Ann and Robert H. Lurie Childrens Hospital of Chicago;
Kristian Schafernak, MD, MPH, Ann and Robert H. Lurie Childrens Hospital of Chicago;
Reggie E Duerst, MD, Ann & Robert H. Lurie Children's Hospital of Chicago;
William T Tse, MD, PhD, Children's Memorial Research Center;
Morris Kletzel, MD, FAAP, MBA, Northwestern University Feinberg School of Medicine;
Jennifer Schneiderman, MD, MS, Ann & Robert H. Lurie Children's Hospital of Chicago
Successful Treatment of Secondary Graft Failure Following Unrelated Cord Blood Transplant with Hematopoietic Growth Factors in a Patient with Fanconi Anemia
David Buchbinder, MD, Children's Hospital of Orange County;
Loan Hsieh, MD, Children's Hospital of Orange County;
Arash Mahajerin, MD, Children's Hospital of Orange County;
Geetha Puthenveetil, MD, Children's Hospital of Orange County;
Amit Soni, MD, Children's Hospital of Orange County;
Diane Jean Nugent, MD, Children's Hospital of Orange County
Outcomes after Allogeneic Stem Cell Transplantation for Patients with Non-Hodgkin Lymphoma: Texas Children's Hospital Experience 1999-2013
Swati Naik, MD, Baylor College of Medicine, Texas Children's Hospital;
Paul Castillo, M.D., Baylor College of Medicine - Cell and Gene Therapy Center - Texas Children's Hospital;
Caridad Martinez, MD, Baylor College of Medicine, Texas Children's Hospital;
Kathryn Leung, MD, Baylor College of Medicine, Texas Children's Hospital;
Ghadir Sasa, MD, Baylor College of Medicine, Texas Children's Hospital;
Stephen Gottschalk, Baylor College of Medicine;
Nabil M Ahmed, MD, MPH, Baylor College of Medicine, Texas Children's Hospital;
Carl Allen, MD, PhD, Baylor College of Medicine, Texas Children's Hospital;
Robert A. Krance, MD, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital and Texas Children's Hospital;
Malcolm K. Brenner, MD, PhD, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital and Texas Children's Hospital;
Helen E. Heslop, MD, Baylor College of Medicine, Texas Children's Hospital, Houston Methodist Hospital
The Clinical Significance of Non-Tuberculosis Mycobacterium (NTM) Infection in Pediatric Hematopoietic Cell Transplant (HCT) Recipients
Alicia Chang, MD, Columbia University Medical Center;
Marc Foca, Columbia University;
Zhezhen Jin, PhD, Columbia University;
Courtney Baker, Children's Hospital of NY Presbyterian;
James Garvin, MD, PhD, Columbia University;
Diane George, MD, Columbia University;
Andrew Kung, MD, PhD, Columbia University;
Prakash Satwani, MD, Columbia University Medical Center;
Monica Bhatia, MD, Columbia University
Targeted Next-Generation Sequencing Panel for Clinical Diagnostic in Inherited Bone Marrow Failure Syndromes Benefit for Pediatric HSCT
Jing Chen, Shanghai Jiaotong University, School of Medicine;
Chengjuan Luo, shanghai children's medical center;
Jiangmin Wang, Shanghai jiaotong university school of medicine shanghai children's medical center;
Changying Luo, shanghai jiaotong university,school of medicine,shanghai children's medical center;
Jian Wang, Molecular Diagnostic Laboratory, Shanghai Children’s Medical Center, Shanghai Jiaotong University School of Medicine;
Qihua Fu, Molecular Diagnostic Laboratory, Shanghai Children’s Medical Center, Shanghai Jiaotong University School of Medicine;
Yiping Shen, Gene Diagnostic Laboratory, Boston Children’s Hospital, Harvard Medical School, Boston, USA
Upfront Alternate Donor HSCT for Children with Severe Aplastic Anemia: A Single Center Prospective Clinical Trail Outcome
Jing Chen, Shanghai Jiaotong University, School of Medicine;
Chengjuan Luo, shanghai children's medical center;
Changying Luo, shanghai jiaotong university,school of medicine,shanghai children's medical center;
Jiangmin Wang, Shanghai jiaotong university school of medicine shanghai children's medical center;
Xia Qin, Shanghai Jiao Tong University, School of Medicine, Shanghai Children’s Medical Center;
Kangli Xu, Shanghai Jiao Tong University, School of Medicine, Shanghai Children’s Medical Center;
Binghua Zhang, Shanghai Jiao Tong University, School of Medicine, Shanghai Children’s Medical Center
Hyperthyroidism As a Complication Following Myloablative Therapy and Stem Cell Transplantation for Childhood Diseases
Gil Ciocci, MSN, FNP, Duke University Medical Center;
Lauren Stafford, MSN, PNP, Duke University Medical Center;
Timothy A Driscoll, MD, Duke University Medical Center;
Paul L. Martin, MD, PhD, Duke University Medical Center;
Joanne Kurtzberg, MD, Duke University Medical Center
Neuroblastoma Stem Cells: Identifying Two New Classes of Drugs with in-Vitro Activity in Cell Populations with High Side-Population Profiles
Don W Coulter, MD, University of Nebraska Medical Center;
Tim McGuire, PharmD, University of Nebraska Medical Center;
Erin McIntyre, University of Nebraska Medical Center;
Tracy Farrell, University of Nebraska Medical Center;
Jonathan Vennerstrom, Ph.D., University of Nebraska Medical Center;
Yuxiang Dong, Ph.D., University of Nebraska Medical Center;
John G Sharp, Ph.D., University of Nebraska Medical Center
Prospective Echocardiographic Screening for Cardiac Dysfunction 100 Days after Transplant in Children and Young Adults after Stem Cell Transplant
Christopher E Dandoy, MD, MSc, Cincinnati Children's Hospital Medical Center;
Thomas D Ryan, Cincinnati Children's Hospital Medical Center;
John L Jefferies, Cincinnati Children's Hospital Medical Center;
Michelle Cash, MSN, CNP, Cincinnati Children's Hospital Medical Center;
Ranjit Chima, MD, Cincinnati Children's Hospital Medical Center;
Javier El-Bietar, MD, Cincinnati Children's Hospital Medical Center;
Russel Hirsch, MD, Cincinnati Children's Hospital Medical Center;
Adam Lane, PhD, Cincinnati Children's Hospital Medical Center;
Kasiani C. Myers, MD, Cincinnati Children's Hospital Medical Center;
Zachary Paff, MSN, Cincinnati Children's Hospital Medical Center;
Stella M. Davies, MBBS, PhD, MRCP, Cincinnati Children's Hospital Medical Center;
Sonata Jodele, MD, Cincinnati Children's Hospital Medical Center
Prospective Pilot Study Evaluating Sleep Disruption in Children and Young Adults Undergoing Stem Cell Transplantation
Christopher E Dandoy, MD, MSc, Cincinnati Children's Hospital Medical Center;
Kristen M. Coleman, RN, BSN, Cincinnati Children's Hospital Medical Center;
Lisa Petiniot, MD, Cincinnati Children's Hospital Medical Center;
Laura Flesch, MSN, RN, CRNP, Cincinnati Children's Hospital Medical Center;
Kelly Byars, PhD, Cincinnati Children's Hospital Medical Center;
Adam Stuart Nelson, MD, Cincinnati Children's Hospital Medical Center;
Jack Bleesing, MD, PhD, Cincinnati Children's Hospital Medical Center;
Sharat Chandra, MD, Cincinnati Children's Hospital Medical Center;
Javier El-Bietar, MD, Cincinnati Children's Hospital Medical Center;
Alexandra Filipovich, MD, Cincinnati Children's Hospital Medical Center;
Michael S. Grimley, MD, Cincinnati Children's Hospital Medical Center;
Sonata Jodele, MD, Cincinnati Children's Hospital Medical Center;
Michael B Jordan, MD, Cincinnati Children's Hospital Medical Center;
Pooja Khandelwal, MD, Cincinnati Children's Hospital Medical Center;
Ashish Kumar, MD, PhD, Cincinnati Children's Hospital Medical Center;
Adam Lane, PhD, Cincinnati Children's Hospital Medical Center;
Rebecca A. Marsh, MD, Cincinnati Children's Hospital Medical Center;
Parinda A. Mehta, MD, Cincinnati Children's Hospital Medical Center;
Kasiani C. Myers, MD, Cincinnati Children's Hospital Medical Center;
Abigail Pate, Cincinnati Children's Hospital Medical Center, Bone Marrow Transplantation and Immune Deficiency;
Gregory Wallace, DO, Cincinnati Children's Hospital Medical Center;
Stella M. Davies, MBBS, PhD, MRCP, Cincinnati Children's Hospital Medical Center;
Dean Beebe, Cincinnati Children's Hospital Medical Center
Incidence and Outcome of Pediatric Hematopoietic Transplant Patients Diagnosed with the New Classification Mucosal Barrier Injury Laboratory-Confirmed Bloodstream Infections (MBI-LCBI)
Christopher E Dandoy, MD, MSc, Cincinnati Children's Hospital Medical Center;
Stella M. Davies, MBBS, PhD, MRCP, Cincinnati Children's Hospital Medical Center;
Evaline Alessandrini, Cincinnati Children's Hospital Medical Center;
Jack Bleesing, MD, PhD, Cincinnati Children's Hospital Medical Center;
Sharat Chandra, MD, Cincinnati Children's Hospital Medical Center;
Lara Danziger-Isakov, MD, Cincinnati Children's Hospital Medical Center;
Kathleen Marie Demmel, BSN, RN, MHA, Cincinnati Children's Hospital;
Javier El-Bietar, MD, Cincinnati Children's Hospital Medical Center;
Alexandra Filipovich, MD, Cincinnati Children's Hospital Medical Center;
Laura Flesch, MSN, RN, CRNP, Cincinnati Children's Hospital Medical Center;
Michael S. Grimley, MD, Cincinnati Children's Hospital Medical Center;
Sonata Jodele, MD, Cincinnati Children's Hospital Medical Center;
Michael B Jordan, MD, Cincinnati Children's Hospital Medical Center;
Pooja Khandelwal, MD, Cincinnati Children's Hospital Medical Center;
Ashish Kumar, MD, PhD, Cincinnati Children's Hospital Medical Center;
Adam Lane, PhD, Cincinnati Children's Hospital Medical Center;
Rebecca A. Marsh, MD, Cincinnati Children's Hospital Medical Center;
Parinda A. Mehta, MD, Cincinnati Children's Hospital Medical Center;
Kasiani C. Myers, MD, Cincinnati Children's Hospital Medical Center;
Rajaram Nagarajan, Cincinnati Children's Hospital Medical Center;
Adam Stuart Nelson, MD, Cincinnati Children's Hospital Medical Center;
Abigail Pate, Cincinnati Children's Hospital Medical Center, Bone Marrow Transplantation and Immune Deficiency;
Gregory Wallace, DO, Cincinnati Children's Hospital Medical Center;
David Haslam, cincinnati Children's Hospital Medical Center;
Beverly Connelly, MD, Cincinnati Children's Hospital Medical Center
Pulmonary Hypertension Associated with Bronchiolitis Obliterans after Stem Cell Transplant
Christopher E Dandoy, MD, MSc, Cincinnati Children's Hospital Medical Center;
Abigail Pate, Cincinnati Children's Hospital Medical Center, Bone Marrow Transplantation and Immune Deficiency;
Mikako Warren, MD, Cincinnati Children's Hospital Medical Center;
Kasiani C. Myers, MD, Cincinnati Children's Hospital Medical Center;
Javier El-Bietar, MD, Cincinnati Children's Hospital Medical Center;
Alexandra Filipovich, MD, Cincinnati Children's Hospital Medical Center;
Russel Hirsch, MD, Cincinnati Children's Hospital Medical Center;
Ranjit Chima, MD, Cincinnati Children's Hospital Medical Center;
Stella M. Davies, MBBS, PhD, MRCP, Cincinnati Children's Hospital Medical Center;
Sonata Jodele, MD, Cincinnati Children's Hospital Medical Center
CT Scan Frequently Misses the Diagnosis of Posterior Reversible Encephalopathy Syndrome (PRES) after Stem Cell Transplant
Christopher E Dandoy, MD, MSc, Cincinnati Children's Hospital Medical Center;
Luke Linscott, Cincinnati Children's Hospital Medical Center;
Stella M. Davies, MBBS, PhD, MRCP, Cincinnati Children's Hospital Medical Center;
Kasiani C. Myers, MD, Cincinnati Children's Hospital Medical Center;
Javier El-Bietar, MD, Cincinnati Children's Hospital Medical Center;
Ranjit Chima, MD, Cincinnati Children's Hospital Medical Center;
Abigail Pate, Cincinnati Children's Hospital Medical Center, Bone Marrow Transplantation and Immune Deficiency;
Hector Wong, Cincinnati Children's Hospital Medical Center;
Sonata Jodele, MD, Cincinnati Children's Hospital Medical Center
A Pilot Study of Donor Enteral Human Milk to Modulate the Gut Microbiome in Children Receiving Stem Cell Transplant
Stella M. Davies, MBBS, PhD, MRCP, Cincinnati Children's Hospital Medical Center;
Cynthia Taggart, RD, Cincinnati Children's Hospital Medical Center;
Kelly E Lake, BS, Cincinnati Children's Hospital Medical Center;
Doyle V Ward, PhD, Broad Institute;
Ardythe L Morrow, PhD, Cincinnati Children’s Hospital Medical Center
Histologic Features of Intestinal Thrombotic Microangiopathy in Patients with High Risk TMA after HSCT
Javier El-Bietar, MD, Cincinnati Children's Hospital Medical Center;
Mikako Warren, MD, Cincinnati Children's Hospital Medical Center;
Christopher E Dandoy, MD, MSc, Cincinnati Children's Hospital Medical Center;
Kasiani C. Myers, MD, Cincinnati Children's Hospital Medical Center;
Adam Lane, PhD, Cincinnati Children's Hospital Medical Center;
Gregory Wallace, DO, Cincinnati Children's Hospital Medical Center;
Stella M. Davies, MBBS, PhD, MRCP, Cincinnati Children's Hospital Medical Center;
Sonata Jodele, MD, Cincinnati Children's Hospital Medical Center
Good Outcome of RSV Infection without Ribavirin Treatment in Pediatric Bone Marrow Transplantation
Javier El-Bietar, MD, Cincinnati Children's Hospital Medical Center;
Adam Stuart Nelson, MD, Cincinnati Children's Hospital Medical Center;
Gregory Wallace, DO, Cincinnati Children's Hospital Medical Center;
Christopher E Dandoy, MD, MSc, Cincinnati Children's Hospital Medical Center;
Sonata Jodele, MD, Cincinnati Children's Hospital Medical Center;
Kasiani C. Myers, MD, Cincinnati Children's Hospital Medical Center;
Stella M. Davies, MBBS, PhD, MRCP, Cincinnati Children's Hospital Medical Center;
Lara Danziger-Isakov, MD, MPH, Cincinnati Children's Hospital Medical Center
A Pilot Trial of Unrelated Cord Blood Transplantation (UCBT) and Unmatched Human Placental Derived Stem Cells (HPDSC) in Children and Young Adults with Malignant and Non-Malignant Disease
Mona Elmacken, MD, New York Medical College;
Michael A. Pulsipher, MD, University of Utah School of Medicine;
Qiuhu Shi, PhD, New York Medical College;
Roger Giller, MD, The Children's Hospital, Denver, University of Colorado School of Medicine;
Theodore B Moore, MD, David Geffen School of Medicine at UCLA;
Lauren Harrison, RN, New York Medical College;
Erin Morris, RN, BSN, New York Medical College;
Olga Militano, PharmD, New York Medical College;
Janet Ayello, MS, MT(ASCP), New York Medical College;
Mildred Semidei-Pomales, BA, MS, New York Medical College;
Sandra Fabricatore, RN, MSN, CPN, New York Medical College;
Xiaokui Zhang, PhD, Celgene Cellular Therapeutics;
Jodi Gurney, Celgene Cellular Therapeutics;
Jessica Hochberg, MD, New York Medical College;
Lee-Ann Baxter Lowe, PhD, Children’s Hospital of Los Angeles;
Mitchell S. Cairo, MD, New York Medical College
Allogeneic Stem Cell Transplantation Is Superior to Immunosuppressive Therapy in Children with Aplastic Anaemia – a Single Centre Analysis from India
Biju George, MD, Christian Medical College;
Auro Viswabandya, MD, Christian Medical College;
Aby Abraham, MD, Christian Medical College;
Kavitha Lakshmi, MSc, Christian Medical College;
Abhijeet Ganapule, MD, Christian Medical College;
Fouzia N A, MD, Christian Medical College;
Anu Korula, MD, Christian Medical College;
Alok Srivastava, MD, Christian Medical College;
Vikram Mathews, MD, Christian Medical College
Forced Deflation PFT: A Novel Method to Evaluate Lung Function in Infants and Young Children
Rakesh K Goyal, MD, Children's Hospital of Pittsburgh of UPMC;
Azada Ibrahimova, MD, Children's Hospital of Pittsburgh of UPMC;
Maria L Escolar, MD, Children's Hospital of Pittsburgh of UPMC;
Paul Szabolcs, MD, Children's Hospital of Pittsburgh of UPMC;
Mark Vander Lugt, MD, Children's Hospital of Pittsburgh of UPMC;
Randy M Windreich, MD, Children's Hospital of Pittsburgh of UPMC;
Daniel J Weiner, MD, Children¹s Hospital of Pittsburgh of UPMC
Progression of Cerebral Vascular Disease Post Transplant in a Child with Prior Sickle Cell Disease
Renee C Gresh, DO, Nemours/AI duPont Children's Hospital;
Corinna L Schultz, MD, MSHP, Nemours/AI duPont Children's Hospital;
Vinay Kandula, MD, Nemours/AI duPont Children's Hospital;
Joseph H Piatt Jr., MD, FAAP, Nemours/AI duPont Children's Hospital;
Emi Caywood, MD, A.I. duPont Hospital for Children of the Nemours Foundation;
Robin Miller, MD, AI DuPont Hospital for Children;
E. Anders Kolb, MD, A I duPont Hospital for Children
Leukocyte Adhesion Deficiency Type I: The Outcome of Reduced- Intensity Conditioning Hematopoietic Stem Cell Transplantation
Amir Ali Hamidieh, M.D., Tehran University of Medical Sciences;
Zahra Pourpak, M.D., Immunology, Asthma, and Allergy Research Institute, Tehran University of Medical Sciences;
Maryam Behfar, M.D., Tehran University of Medical Sciences;
Sara Faghihi-Kashani, M.D., M.P.H., Tehran University of Medical Sciences;
Mohammad Reza Fazlollahi, M.D., Immunology, Asthma, and Allergy Research Institute, Tehran University of Medical Sciences;
Ashraf sadat Hosseini, Tehran University of Medical Sciences;
Mostafa Moin, M.D., Immunology, Asthma, and Allergy Research Institute, Tehran University of Medical Sciences;
Ardeshir Ghavamzadeh, M.D., Tehran University of Medical Sciences
Fludarabine Combined with Myeloablative Busulfan (FluBu4) Results in Reliable Engraftment and Low Transplant-Related Mortality in Pediatric Patients
Andrew C. Harris, M.D., University of Michigan;
Thomas Braun, PhD, University of Michigan;
Craig A Byersdorfer, M.D., Ph.D., University of Michigan;
Sung Won Choi, M.D., University of Michigan;
James A Connelly, MD, University of Michigan;
Carrie L. Kitko, MD, University of Michigan;
Gregory Yanik, MD, University of Michigan;
John Levine, MD, MS, University of Michigan
Title - Reduced Intensity Conditioning in Transplants for Patients with Sickle Cell Disease: Effect of “Late” Alemtuzumab
Akshat Jain, MD, Hofstra North Shore-LIJ School of Medicine;
Indira Sahdev, MD, Cohen Children's Medical Center of NY;
Joel Brochstein, MD, Cohen Children's Medical Center of NY;
Nan Werther, RN, MS, CPNP, Steven and Alexandra Cohen Children’s Medical Center of New York
BMT Outcomes for Rare Pediatric Diseases at the Medical University of South Carolina
Lori Burton Donahoo, MSN, APRN, CPNP, Medical University of South Carolina;
Julie Heh, PharmD, MUSC;
Amanda Littleton, R, BSN, OCN, MUSC;
Stacey Warneke, RN, BSN, CPHON, MUSC;
Cindy Kramer, RN, BSN, OCN, MUSC;
Michelle Hudspeth, MD, Medical University of South Carolina;
Jennifer Joi Jaroscak, MD, Medical University of South Carolina
Eculizumab Treatment Improves Survival in Patients with High-Risk Hematopoietic STEM CELL Transplant (HSCT)-Associated Thrombotic Microangiopathy (TMA)
Sonata Jodele, MD, Cincinnati Children's Hospital Medical Center;
Benjamin Laskin, MD, MS, Cincinnati Children's Hospital Medical Center, Cincinnati;
Tsuyoshi Fukuda, PhD, Cincinnati Childen's Hospital Medical Center;
Alexander Vinks, PharmD, PhD, FCP, Cincinnati Children's Hospital Medical Center;
Kana Mizuno, Cincinnati Children's Hospital Medical Center;
Jens Goebel, MD, Cincinnati Children's Hospital Medical Center;
Kasiani C. Myers, MD, Cincinnati Children's Hospital Medical Center;
Jack Bleesing, MD, PhD, Cincinnati Children's Hospital Medical Center;
Michael S. Grimley, MD, Cincinnati Children's Hospital Medical Center;
Javier El-Bietar, MD, Cincinnati Children's Hospital Medical Center;
Christopher E Dandoy, MD, MSc, Cincinnati Children's Hospital Medical Center;
Ashley Teusink, PharmD, MBA, BCPS, Cincinnati Children's Hospital Medical Center;
Adam Lane, PhD, Cincinnati Children's Hospital Medical Center;
Stella M. Davies, MBBS, PhD, MRCP, Cincinnati Children's Hospital Medical Center
Drug Resistant CMV in Pediatric Hematopoietic Stem Cell Transplant Recipients
Tami John, MD, CHOC Children's Hospital of Orange County;
Steven Neudorf, MD, CHOC Children's Hospital of Orange County;
Ivan Kirov, MD, Children's Hospital of Orange County;
Negar Ashouri, MD, Children's Hospital of Orange County;
Van Huynh, MD, CHOC Children's Hospital of Orange County
Trend, Risk Factors and Outcome of Respiratory Syncytial Viral Infection in Pediatric Hematopoietic Stem Cell Transplant Recipients: A Multi-Institutional Review
Ram Kalpatthi, MD, Children's Mercy Hospital;
Matt Hall, PhD, Children's Hospital Association;
Nazia Tabassum, Children's Mercy Hospital;
Nancy Shreve, MS, Children's Mercy Hospital;
Leigh Casey, Children's Mercy Hospital;
Jignesh Dalal, MD, Children's Mercy Hospital
Viral-Specific T Lymphocytes for Treatment of Viral Infections in Primary Immunodeficiency
Michael Daniel Keller, MD, Children's National Medical Center;
Catherine M. Bollard, MD, Children's National Medical Center;
Patrick J Hanley, PhD, Children's National Medical Center;
Sarah McCormack, Children's National Medical Center;
Jennifer Heimall, MD, The Children's Hospital of Philadelphia;
Nancy Bunin, MD, Children's Hospital of Philadelphia;
Brett Loechelt, MD, Children's National Medical Center;
Soma Jyonouchi, MD, Children's Hospital of Philadelphia
Reduced Intensity Transplantation for Inherited Bone Marrow Failure Syndromes
Alok Kothari, MD, Washington University School of Medicine;
Shalini Shenoy, MD, Washington University, St. Louis Children's Hospital;
Robert J. Hayashi, MD, St. Louis Children's Hospital, University of Washington;
Paul Haut, MD, Riley Hospital for Children/Indiana University;
Jeffrey H Davis, MD, British Columbia Children's Hospital;
Alexander Ngwube, Baylor College of Medicine, Texas Children's Hospital;
Lisa Murray, MA, Washington University;
Brett Loechelt, MD, Children's National Medical Center
Children after Allogeneic Hematopoietic Cell Transplantation Can Develop BK Virus Nephropathy: Pilot Data Using Urinary Polyomavirus-Haufen Testing
Benjamin Laskin, MD, MS, The Children's Hospital of Philadelphia;
Harsharan K Singh, MD, The University of North Carolina School of Medicine;
David Witte, MD, Cincinnati Children's Hospital Medical Center;
Sonata Jodele, MD, Cincinnati Children's Hospital Medical Center;
Stella M. Davies, MBBS, PhD, MRCP, Cincinnati Children's Hospital Medical Center;
Christopher E Dandoy, MD, MSc, Cincinnati Children's Hospital Medical Center;
Jens Goebel, MD, Cincinnati Children's Hospital Medical Center;
Volker Nickeleit, MD, The University of North Carolina School of Medicine
Routine Bone Marrow and CSF Analysis Following Allogeneic Hematopoietic Cell Transplantation (AlloHCT) in Children with Leukemia: Lack of Consensus and Questionable Utility
Anya Levinson, Columbia University;
Staci Arnold, MD, MBA, Columbia University;
Andrew Kung, MD, PhD, Columbia University;
Monica Bhatia, MD, Columbia University;
Diane George, MD, Columbia University;
James Garvin, MD, PhD, Columbia University;
Prakash Satwani, MD, Columbia University
Alemtuzumab, Fludarabine, and Melphalan Reduced Intensity Conditioning Hematopoietic Cell Transplantation: Experience in over 200 Pediatric and Young Adult Patients with Primary Immune Deficiency, Metabolic, and Marrow Failure Disorders
Rebecca A. Marsh, MD, Cincinnati Children's Hospital Medical Center;
Marepalli B Rao, PhD, University of Cincinnati;
Aharon Gefen, MD, MSc, Rappaport Faculty of Medicine, Technion-Israel Institute of Technology;
Denise Bellman, CRC, Cincinnati Children's Hospital Medical Center;
Parinda A. Mehta, MD, Cincinnati Children's Hospital Medical Center;
Pooja Khandelwal, MD, Cincinnati Children's Hospital Medical Center;
Sharat Chandra, MD, Cincinnati Children's Hospital Medical Center;
Sonata Jodele, MD, Cincinnati Children's Hospital Medical Center;
Kasiani C. Myers, MD, Cincinnati Children's Hospital Medical Center;
Michael S. Grimley, MD, Cincinnati Children's Hospital Medical Center;
Christopher E Dandoy, MD, MSc, Cincinnati Children's Hospital Medical Center;
Javier El-Bietar, MD, Cincinnati Children's Hospital Medical Center;
Ashish Kumar, MD, PhD, Cincinnati Children's Hospital Medical Center;
Tom Leemhuis, PhD, Hoxworth Blood Center;
Kejian Zhang, MD, MBA, Cincinnati Childrens Hospital Medical Center;
Jack Bleesing, MD, PhD, Cincinnati Children's Hospital Medical Center;
Michael B Jordan, MD, Cincinnati Children's Hospital Medical Center;
Alexandra Filipovich, MD, Cincinnati Children's Hospital Medical Center;
Stella M. Davies, MBBS, PhD, MRCP, Cincinnati Children's Hospital Medical Center
Peri-Transplant Alemtuzumab Levels Dictate the Risks of Acute Gvhd and Mixed Chimerism
Rebecca A. Marsh, MD, Cincinnati Children's Hospital Medical Center;
Lisa Neumeier, Cincinnati Children's Hospital;
Lisa Durbin, Cincinnati Children's Hospital;
Sonata Jodele, MD, Cincinnati Children's Hospital Medical Center;
Jack Bleesing, MD, PhD, Cincinnati Children's Hospital Medical Center;
Michael B. Jordan, MD, Cincinnati Children's Hospital;
Stella M. Davies, MBBS, PhD, MRCP, Cincinnati Children's Hospital Medical Center;
Alexandra Filipovich, MD, Cincinnati Children's Hospital Medical Center
Late Endocrine Effects Remain Prevalent Despite Reduced Intensity Chemotherapy for Hematopoietic Stem Cell Transplantation in Children and Young Adults
Kasiani C. Myers, MD, Cincinnati Children's Hospital Medical Center;
Jonathan C. Howell, MD, PhD, Children’s Hospital Medical Center;
Gregory Wallace, DO, Cincinnati Children's Hospital Medical Center;
Christopher E Dandoy, MD, MSc, Cincinnati Children's Hospital Medical Center;
Javier El-Bietar, MD, Cincinnati Children's Hospital Medical Center;
Adam Lane, PhD, Cincinnati Children's Hospital Medical Center;
Susan R Rose, MD, Children’s Hospital Medical Center;
Stella M. Davies, MBBS, PhD, MRCP, Cincinnati Children's Hospital Medical Center;
Sonata Jodele, MD, Cincinnati Children's Hospital Medical Center
Renal Complications in Fanconi Anemia (FA) Patients Undergoing Hematopoietic Cell Transplant (HCT) Using a Uniform Radiation-Free Approach
Adam S Nelson, MBBS, Cincinnati Children's Hospital Medical Center;
Stella M. Davies, MBBS, PhD, MRCP, Cincinnati Children's Hospital Medical Center;
Adam Lane, PhD, Cincinnati Children's Hospital Medical Center;
Kasiani C. Myers, MD, Cincinnati Children's Hospital Medical Center;
Ashley Teusink, PharmD, MBA, BCPS, Cincinnati Children's Hospital Medical Center;
Sonata Jodele, MD, Cincinnati Children's Hospital Medical Center;
Parinda A. Mehta, MD, Cincinnati Children's Hospital Medical Center
Improved Outcomes in Patients with Dyskeratosis Congenita (DC) Undergoing Allogeneic Hematopoietic Cell Transplantation (HCT) Using Reduced Intensity Conditioning
Adam S Nelson, MBBS, Cincinnati Children's Hospital Medical Center;
Stella M. Davies, MBBS, PhD, MRCP, Cincinnati Children's Hospital Medical Center;
Kasiani C. Myers, MD, Cincinnati Children's Hospital Medical Center;
Rebecca A. Marsh, MD, Cincinnati Children's Hospital Medical Center;
Sonata Jodele, MD, Cincinnati Children's Hospital Medical Center;
Leann Mount, Cincinnati Children's Hospital Medical Center;
Tracey A O'Brien, MD, Sydney Children's Hospital;
Parinda A. Mehta, MD, Cincinnati Children's Hospital Medical Center
Reduced Incidence of Infections in Very Young Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
Adam S Nelson, MBBS, Cincinnati Children's Hospital Medical Center;
Gregory Wallace, DO, Cincinnati Children's Hospital Medical Center;
Beverly Connelly, MD, Cincinnati Children's Hospital Medical Center;
Stella M. Davies, MBBS, PhD, MRCP, Cincinnati Children's Hospital Medical Center;
Michael S. Grimley, MD, Cincinnati Children's Hospital Medical Center;
Sonata Jodele, MD, Cincinnati Children's Hospital Medical Center;
Lara Danziger-Isakov, MD, Cincinnati Children's Hospital Medical Center
Outcome of Hematopoietic Stem Cell Transplantation for Children with Severe Combined Immunodeficiency (SCID). Seventeen Years Experience in Single Pediatric Transplantation Center
Neta Nevo, MD, Rambam Medical Center;
Amos Etzioni, MD, Prof, Rambam Medical Center;
Myriam Ben Arush, MD, Prof, Rambam Medical Center;
Halil Abdalla, MD, Rambam Medical Center;
Ronit Elhasid, MD, Tel-Aviv Sourasky Medical Center;
Irina Zaidman, MD, PhD, Rambam Medical Center
Mixed Donor Chimerism after Allogeneic Transplant in Patients with Wiskott-Aldrich Syndrome
Alexander Ngwube, Baylor College of Medicine, Texas Children's Hospital;
Lisa Forbes, MD, Baylor College of Medicine, Texas Children's Hospital;
Robert A. Krance, MD, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital and Texas Children's Hospital;
Malcolm Brenner, MD, PhD, Baylor College of Medicine, Houston Methodist Hospital and Texas Children's Hospital;
Helen E. Heslop, MD, Baylor College of Medicine, Texas Children's Hospital, Houston Methodist Hospital;
Kathryn Leung, MD, Baylor College of Medicine, Texas Children's Hospital;
Imelda C Hanson, MD, Baylor College of Medicine, Texas Children's Hospital;
Ghadir Sasa, MD, Baylor College of Medicine, Texas Children's Hospital;
Howard Rosenblatt, MD, Baylor College of Medicine;
Ann M. Leen, PhD, Baylor College of Medicine, Texas Children's Hospital, Houston Methodist Hospital;
William Shearer, MD, PhD, Baylor College of Medicine, Texas Children's Hospital;
Swati Naik, MD, Baylor College of Medicine, Texas Children's Hospital;
Nabil M Ahmed, MD, MPH, Baylor College of Medicine, Texas Children's Hospital;
Stephen Gottschalk, MD, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital and Texas Children's Hospital;
Carl Allen, MD, PhD, Baylor College of Medicine, Texas Children's Hospital;
Caridad Martinez, MD, Baylor College of Medicine, Texas Children's Hospital
Factors Associated with CMV Disease in Pediatric Hematopoietic Stem Cell Transplantation
Robert Grant Rowe, MD, PhD, Dana-Farber Cancer Institute;
Christine Duncan, MD, Dana-Farber Cancer Institute;
Steven Margossian, MD PhD, Dana-Farber Cancer Institute;
Michelle Lee, MD, PhD, Dana-Farber Cancer Institute;
Leslie E. Lehmann, MD, Dana-Farber Cancer Institute
Late Onset Pulmonary Arterial Hypertension after Successful HSCT for Familial HLH
Andrea R Whitfield, DO, Medical University of South Carolina;
Michael Caplan, MD, Suffolk County Office of the Medical Examiner;
Ryan Butts, MD, Medical University of South Carolina;
Susan E Presnell, MD, Medical University of South Carolina;
Michelle Hudspeth, MD, Medical University of South Carolina
"WE CAN Work IT out": The Development of a Consensus Approach to Decision Making in Allogeneic STEM CELL Transplantation in the UK
Robert F. Wynn, MD, Royal Manchester Children's Hospital;
Paul Veys, MBBS, Great Ormond Street Hospital for Children;
Colin G Steward, MD, Royal Hospital for Sick Children;
Ajay Vora, MD, Sheffield Children's Hospital;
Roderick Skinner, PhD, Newcastle University, Royal Victoria Infirmary;
Brenda Gibson, Royal Hospital for Sick Children;
Mark Velangi, Birmingham Children's Hospital;
Rachael Hough, University College Hospital London;
Michael Potter, Royal Marsden Hospital;
Josu de la Fuente, PhD FRCP MRCPCH FRCPath, Imperial College London;
Persis Amrolia, MD, PhD, Great Ormond Street Hospital for Children NHS Trust;
Owen Smith, Our Lady's Children's Hospital Crumlin;
Beki James, Leeds General Infirmary
Outcome of Hematopoietic Stem Cell Transplantation (HSCT) for Pediatric Patients with Hemoglobinopathy. Fifteen Years Experience in One Pediatric Transplant Center
Irina Zaidman, MD, PhD, Rambam Medical Center;
Myriam Ben Arush, MD, Prof, Rambam Medical Center;
Khalil Abdalla, MD, Rambam Medical Center;
Aharon Gefen, MD, MSc, Rappaport Faculty of Medicine, Technion-Israel Institute of Technology;
Neta Nevo, MD, Rambam Medical Center;
Iris Porat, RN, Rambam Medical Center;
Ronit Elhasid, MD, Tel-Aviv Sourasky Medical Center
Unrelated Donor Hematopoietic Stem Cell Transplantation for Treatment of Non-Malignant Genetic Diseases Using a Myeloablative Reduced Toxicity Conditioning Regimen
Hisham Abdel-Azim, MD, Children's Hospital Los Angeles;
Quan Zhao, MD, Children's Hospital Los Angeles;
Kris Michael Mahadeo, MD, MPH, Children's Hospital Los Angeles;
Sajad Khazal, MD, Children's Hospital Los Angeles;
Donald B. Kohn, MD, Mattel Children's Hospital, University of California, Los Angeles;
Gay M Crooks, MB BS, Mattel Children's Hospital, University of California, Los Angeles;
Ami J Shah, MD, Mattel Children's Hospital, University of California, Los Angeles;
Neena Kapoor, MD, Children's Hospital Los Angeles
![[Visit Client Website]](images/banner.gif)